-
1
-
-
9244252037
-
The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activation
-
Nielsen VG, Lyerly RT, Gurley WQ. The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activation. Anesth Analg 2004; 99:1587-1592.
-
(2004)
Anesth Analg
, vol.99
, pp. 1587-1592
-
-
Nielsen, V.G.1
Lyerly, R.T.2
Gurley, W.Q.3
-
2
-
-
14644440824
-
Effects of coagulation factor deficiency on plasma coagulation kinetics determined via Thrombelastography®: Critical roles of fibrinogen and Factors II, VII, X and XII
-
Nielsen VG, Cohen BM, Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via Thrombelastography®: critical roles of fibrinogen and Factors II, VII, X and XII. Acta Anaesthesiol Scand 2005; 49:222-231.
-
(2005)
Acta Anaesthesiol Scand
, vol.49
, pp. 222-231
-
-
Nielsen, V.G.1
Cohen, B.M.2
Cohen, E.3
-
3
-
-
23944480854
-
Colloids decrease clot propagation and strength: Role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions
-
Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 2005; 49:1163-1171.
-
(2005)
Acta Anaesthesiol Scand
, vol.49
, pp. 1163-1171
-
-
Nielsen, V.G.1
-
4
-
-
31644436226
-
Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation
-
Nielsen VG, Cohen BM, Cohen E. Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation. Blood Coagul Fibrinolysis 2006; 17:75-81.
-
(2006)
Blood Coagul Fibrinolysis
, vol.17
, pp. 75-81
-
-
Nielsen, V.G.1
Cohen, B.M.2
Cohen, E.3
-
5
-
-
33644778049
-
Effects of aprotinin on plasma coagulation kinetics determined by thrombelastography: Role of factor XI
-
Nielsen VG. Effects of aprotinin on plasma coagulation kinetics determined by thrombelastography: role of factor XI. Acta Anaesthesiol Scand 2006; 50:168-172.
-
(2006)
Acta Anaesthesiol Scand
, vol.50
, pp. 168-172
-
-
Nielsen, V.G.1
-
6
-
-
33646827821
-
Protamine enhances fibrinolysis by decreasing clot strength: Role of tissue factor-initiated thrombin generation
-
Nielsen VG. Protamine enhances fibrinolysis by decreasing clot strength: role of tissue factor-initiated thrombin generation. Ann Thorac Surg 2006; 81:1720-1727.
-
(2006)
Ann Thorac Surg
, vol.81
, pp. 1720-1727
-
-
Nielsen, V.G.1
-
7
-
-
33750058284
-
Impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography
-
Audu P, Nielsen VG, Armstead VE, Powell G, Kim J, Kim L, Mehta M. Impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography. Anesth Analg 2006; 103:841-845.
-
(2006)
Anesth Analg
, vol.103
, pp. 841-845
-
-
Audu, P.1
Nielsen, V.G.2
Armstead, V.E.3
Powell, G.4
Kim, J.5
Kim, L.6
Mehta, M.7
-
8
-
-
22444435270
-
Antithrombin efficiency is maintained in vitro in human plasma following dilution with hydroxyethyl starches
-
Nielsen VG. Antithrombin efficiency is maintained in vitro in human plasma following dilution with hydroxyethyl starches. Blood Coagul Fibrinolysis 2005; 16:319-322.
-
(2005)
Blood Coagul Fibrinolysis
, vol.16
, pp. 319-322
-
-
Nielsen, V.G.1
-
9
-
-
33845779900
-
High molecular weight hydroxyethyl starch accelerates kallikrein-dependent clot initiation
-
in press
-
Nielsen VG. High molecular weight hydroxyethyl starch accelerates kallikrein-dependent clot initiation. J Trauma, in press.
-
J Trauma
-
-
Nielsen, V.G.1
-
10
-
-
0038554771
-
Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation
-
Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1:551-558.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 551-558
-
-
Sorensen, B.1
Johansen, P.2
Christiansen, K.3
Woelke, M.4
Ingerslev, J.5
-
11
-
-
33646758200
-
Argatroban, bivalirudin and lepirudin do not decrease clot propagation and strength as effectively as heparin activated antithrombin in vitro
-
Nielsen VG, Steenwyk BL, Gurley WQ, Pereira SJ, Lell WA, Kirklin JK. Argatroban, bivalirudin and lepirudin do not decrease clot propagation and strength as effectively as heparin activated antithrombin in vitro. J Heart Lung Transpl 2006; 25:653-663.
-
(2006)
J Heart Lung Transpl
, vol.25
, pp. 653-663
-
-
Nielsen, V.G.1
Steenwyk, B.L.2
Gurley, W.Q.3
Pereira, S.J.4
Lell, W.A.5
Kirklin, J.K.6
|